Can a single eye injection shrink melanoma and save sight?
Disease control
Not yet recruiting
This early-phase trial is testing an investigational drug called RBP-01 (sotrastaurin), given as an injection into the eye, for people with primary uveal melanoma—a rare cancer of the eye. The study aims to see if the drug is safe and whether it can shrink the tumor enough to avo…
Phase: PHASE1, PHASE2 • Sponsor: ReBio Pharma • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC